Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…
Pole-mount Agrivoltaics Project at Puerto Rico Coffee Farm A new agrivoltaics system has been installed at a coffee farm in Adjuntas, Puer…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
Installing Microsoft Store in Windows Sandbox with PowerShell Script Windows Sandbox, a lightweight virtual desktop, can now have Microsof…
Prairie Portraits: Alex Rapp The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that expanding the Rolex 24 grid is currently…
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…
A Studio With a Heated Solarium on West 14th for $780,000 For under a million dollars, various housing configurations are available, inclu…